Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples. - Wikidata - awgldk - TriplyDB

Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples.

Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples.

http://www.wikidata.org/entity/Q38232016

about

Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation Degradation and Stabilization of Peptide Hormones in Human Blood Specimens Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations.(E)-Propyl α-Cyano-4-Hydroxyl Cinnamylate: A High Sensitive and Salt Tolerant Matrix for Intact Protein Profiling by MALDI Mass Spectrometry.Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.Assessment of Blood Contamination in Biological Fluids Using MALDI-TOF MS.Neuroproteomic profiling of human body fluids.Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group.

P2860

Q26801663-1D7BDDE8-3D8C-4B8A-AEE7-698FBDE9383B Q28546842-150F0486-DDE0-4F2C-8288-D30C7625F7C0 Q35880037-0ED4BC95-C831-4224-A919-DA70B531F032 Q35884809-B5A65505-5E0E-4B82-A858-293CCED6CE39 Q35938561-E01707AB-0B3A-4930-9253-53ABE8183847 Q35972751-C3910AC3-4A2D-4688-A82D-14B0C70FC117 Q38569255-DCFA37BF-8E40-44F3-8FF6-9216A0DB3A08 Q39413046-726BE848-810F-4EAE-B8B9-C5607510DB46 Q46192276-277E9CE7-5B4A-498A-885C-F4EEF0A19CF0

P2860

Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples.

http://www.wikidata.org/entity/Q38232016

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Direct analytical sample quali ...... g cerebrospinal fluid samples.

@en

type

label

Direct analytical sample quali ...... g cerebrospinal fluid samples.

@en

prefLabel

Direct analytical sample quali ...... g cerebrospinal fluid samples.

@en

P1433

Q38232016-1F29B85C-2F3A-4D09-AD1F-2110679BD706

P1476

Q38232016-54FC7DC2-AF8F-4759-8993-BA9AB0C00950

P2093

Q38232016-1F731D2F-8781-46B9-871E-C2230C18A3FF

Q38232016-366D65E7-91FB-4C3A-AF56-CE5C35E690FB

Q38232016-4A6E7222-A2F6-4323-B490-E4281318FBD8

Q38232016-59E74906-B5DE-4A56-9AAE-88AC258B67BB

Q38232016-63E7D7D7-2FD7-45DF-BCFC-13015EAC9A0A

Q38232016-AFDE4E1E-C930-4B99-9025-DFF4F49D54ED

P2860

Q38232016-01DAC72E-7CF7-442C-8CBB-3E17E28505B8

Q38232016-05B0E0B4-E692-450E-8DD5-5EF38473CB3E

Q38232016-0638299F-ACBD-4B86-B2A4-1584926E7C6F

Q38232016-17770BCA-61E3-4A21-A775-AC38925D2794

Q38232016-1AA2BCB2-0995-4B19-A635-C7132D3F4B25

Q38232016-1B91DA45-7E8D-4E3A-BF9A-95C896D4A9BD

Q38232016-24B86BAF-BF26-4E56-B875-518BA9AF7DCF

Q38232016-2BF32E18-93BF-4A86-A51F-2ABFF9748AF3

Q38232016-2E6849EB-CE47-4F54-BBED-2C49EB0E428F

Q38232016-327A2529-8BF6-48F6-B77E-11A1699FB04D

P304

Q38232016-0190D605-152D-4063-A847-F9AF335A1521

P31

Q38232016-858AE446-8623-4840-B566-832AD4D61187

P356

Q38232016-6603C839-7EA4-43CA-9998-CB2380D6143A

P433

Q38232016-BD5B5008-25A3-4C36-B6E7-ECD3418ED86F

P478

Q38232016-A5E3D347-25CC-4C10-B43C-A12B08E4F134

P50

Q38232016-81E5960B-996A-4919-9BDC-B0A8ED91B3A3

Q38232016-DC4655D2-F944-4125-89FC-D592FC83B9A0

P577

Q38232016-88D477F9-031F-4F53-831B-BEF6158644DA

P698

Q38232016-1DBC6350-A07D-4686-89BC-F5CD541002D1

P921

Q38232016-210C822B-1AC9-46EC-987C-EE0EB78F56BF

Q38232016-FFB7E2D9-3314-4405-A1D9-FF28B0F54F19

P356

P1433

P1476

Direct analytical sample quali ...... g cerebrospinal fluid samples.

@en

P2093

Andrea Urbani

http://www.w3.org/2001/XMLSchema#string

Cristian Piras

http://www.w3.org/2001/XMLSchema#string

Damiana Pieragostino

http://www.w3.org/2001/XMLSchema#string

Jens Wiltfang

http://www.w3.org/2001/XMLSchema#string

Sergio Bernardini

http://www.w3.org/2001/XMLSchema#string

Viviana Greco

http://www.w3.org/2001/XMLSchema#string

P2860

Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models

Cleavage of cystatin C is not associated with multiple sclerosis

Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

The impact of blood contamination on the proteome of cerebrospinal fluid.

Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.

Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis.

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.

CSF biomarkers for improved prognostic accuracy in acute CNS disease.

The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).

P304

1954-1962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PMIC.201300565

http://www.w3.org/2001/XMLSchema#string

P433

17-18

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Caltagirone

Ruedi Aebersold

P577

2014-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25044759

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid